switching from mounjaro to semaglutide New obesity drug launches in Korea — is it worth Wegovy? Switching From Ozempic to Mounjaro:

Managing nausea is therefore a key part of managing fatigue

Review of screenshots for electronic implementation of EORTC instruments Dagmara Kulis 1 , Anas Simon 1 , Jens Lehmann 2 1 EORTC, Brussels, Belgium, 2 Medical University of Innsbruck, Innsbruck, Austria Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2038 Aims With reducing timelines to start of trials being a priority for sponsors, migration of patient-reported outcome (PRO) measures onto electronic platforms as ePROs remains a process perceived as excessively long, especially due to the copyright holder review (CHR) of the screenshots

A review of thirty-seven studies published in the BMJ found that people who stop GLP-1 obesity drugs typically regain nearly a pound a month

This low risk of hypoglycemia with DPP-4 inhibition is also underlined in guidelines and position documents (100, 101)

Current evidence does not confirm a direct causal link, though mood changes are being monitored as a potential rare side effect